FDA cleared the Arm Blood Pressure Monitor Models: ARM-30C+; ARM-30M+; ARM-HA101+; ARM-3060; XS Pro; ARM-30G1; ARM-30H; Visomat double comfort; Visomat comfort 20/40 BT; ARM-3080; ARM-3081; ARM-3082; ARM-3103; ARM-3200; ARM-115; ARM-111; ARM-3102; ARM-3100; ARM-3101; SBM 15; ARM-30W; ARM-30J; ARM-30F-XL; ARM-3024-XL; ARM-3025-XL; ARM-3062-XL; 9S Pro from Shenzhen AOJ Medical Technology Co., Ltd. on Apr 1, 2026 under K260276, a special 510(k). The device falls under product code DXN, System, Measurement, Blood-Pressure, Non-Invasive, regulated at 21 CFR 870.1130 as a Class 2 device. The review panel was Cardiovascular.
FDA logged the submission as received on Jan 29, 2026. The decision came 62 days later, inside the 90 FDA-day goal for a 510(k).
This is the only decision on file for Shenzhen AOJ Medical Technology Co., Ltd. in the last 12 months of the tracker.
Questions & Answers
What did FDA clear under K260276?
K260276 is the FDA 510(k) for Arm Blood Pressure Monitor Models: ARM-30C+; ARM-30M+; ARM-HA101+; ARM-3060; XS Pro; ARM-30G1; ARM-30H; Visomat double comfort; Visomat comfort 20/40 BT; ARM-3080; ARM-3081; ARM-3082; ARM-3103; ARM-3200; ARM-115; ARM-111; ARM-3102; ARM-3100; ARM-3101; SBM 15; ARM-30W; ARM-30J; ARM-30F-XL; ARM-3024-XL; ARM-3025-XL; ARM-3062-XL; 9S Pro, submitted by Shenzhen AOJ Medical Technology Co., Ltd.. FDA's decision date was Apr 1, 2026, under product code DXN (System, Measurement, Blood-Pressure, Non-Invasive).
Who makes the Arm Blood Pressure Monitor Models: ARM-30C+; ARM-30M+; ARM-HA101+; ARM-3060; XS Pro; ARM-30G1; ARM-30H; Visomat double comfort; Visomat comfort 20/40 BT; ARM-3080; ARM-3081; ARM-3082; ARM-3103; ARM-3200; ARM-115; ARM-111; ARM-3102; ARM-3100; ARM-3101; SBM 15; ARM-30W; ARM-30J; ARM-30F-XL; ARM-3024-XL; ARM-3025-XL; ARM-3062-XL; 9S Pro?
Shenzhen AOJ Medical Technology Co., Ltd., based in Shenzhen, is the applicant of record for K260276.
How long did the K260276 review take?
FDA received the submission on Jan 29, 2026 and issued its decision on Apr 1, 2026, 62 days later.